Skip to main content
. 2020 Feb 3;15:31. doi: 10.1186/s11671-020-3252-z

Fig. 7.

Fig. 7

In vitro anticancer efficacy. a Cell viabilities of SK-OV-3 cells after 24 h incubation with different concentration of FA-FRT-PFP. b Cell viabilities of SK-OV-3 cells treated with 40 μg/mL of PBS (control), FRT-PFP, FA-FRT-PFP + FA, and FA-FRT-PFP combined with or without LIFU irradiation (2.0 W/cm2, 4 min) and further 21 h incubation